New Alliance Capital
Shanghai, Shanghainac-capital.com
Overview
New Alliance Capital is a leading Chinese investment firm with AUM of RMB 15 billion across 7 funds. Founded in 2008 in Shanghai, they invest in information technology, healthcare, new energy, and high-tech manufacturing . Their investments are designed to preserve and grow their limited partners' capital .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arnatar Therapeutics | Dec 2024 | Series A | Co-investor |
| Arnatar Therapeutics | Apr 2024 | Series A | Co-investor |
| Eccogene | Jun 2023 | Series B | Lead |
| NeuroXess | Dec 2022 | Series A | Co-investor |
| Kactus Biosystems | Oct 2022 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.